81.9%
KEYTRUDA®GemPharmatech
…eously transplanted with CT26 cells and treated with anti-PD-1 (KEYTRUDA®) twice weekly. Non-responsive tumors were excised, dissociated,…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: KEYTRUDA® ×
KEYTRUDA®
This drug is selected. Its supporting articles are shown below.